Certified by Founder Lodge
Epigenic Therapeutics
China - Shanghai
START UP
1 Disclosed Funding Rounds $32,000,000
0 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Epigenic Therapeutics is a frontier biotechnology company dedicated to developing next generation gene editing therapy utilizing regulation of epigenetic genome for a variety of diseases. Fou
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| August, 30 ,2023 | Series A | $32,000,000 | |
| September, 09 ,2025 | Series B | $60,000,000.00 |
OrbiMed
Qiming Venture Partners
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
StretchSense | $2,300,000 | (Dec 23, 2025)
Ciphero | $2,500,000 | (Dec 23, 2025)
LatentForce | $1,700,000 | (Dec 23, 2025)
ZeroPhase | $6,800,000 | (Dec 23, 2025)
beycome | $2,500,000 | (Dec 23, 2025)
